Metabolic signaling integration: IGF-1 shares structural similarity with insulin and interacts with metabolic signaling networks
The temporary program, which runs until the end of 2027, is the first opportunity for most older adults to get GLP-1s, short for glucagon-like peptide-1 receptor agonists, covered by insurance when used strictly for weight loss
The dose can be further be increased every month, up to a maximum dose
Tirzepatide overcomes these limitations by simultaneously activating both GIPR and GLP-1R, thereby harnessing their complementary mechanisms of action [25]
We offer a personalized approach, tailoring the treatment to meet individual health and weight loss goals
This program is ideal for individuals seeking a structured, physician-led solution to weight management